Product: | Elacridar | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 9839 | ||||||||
CAS Number: | 143664-11-3 | ||||||||
Synonyms: |
N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide; GF 120918; GG 918; GW 0918 |
||||||||
Pricing: |
|
||||||||
Formula: | C34H33N3O5 | ||||||||
Chemical Purity: | 98% | ||||||||
Molecular Weight: | 563.64 | ||||||||
Structure: | |||||||||
Appearance: | Yellow solid | ||||||||
Category: | All Inhibitors | ||||||||
Stability: | Stable under recommended storage conditions. | ||||||||
Storage: |
Store in original container in a cool dark place. |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Neville, K., et al.: Clin. Cancer Res., 10, 2525 (2004), Reardon, D., et al.: J. Clin. Oncol. 23, 9359 (2005), Pan, G., et al.: Drug Metab. Dispos., 35, 1165 (2007) |
||||||||
MSDS: | |||||||||
Applications: |
A prototypical BCRP inhibitor. Inhibits the Bcrp1-mediated transport |